Michael Yu

Gramática descriptiva de la lengua española

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Regulatory mechanisms of microRNA expression

Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer

A view on drug resistance in cancer

T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient

The Roles of SIRT1 in Cancer

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Coronavirus disease (COVID-19) cases analysis using machine-learning applications

Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment

Combinations of Bevacizumab With Cancer Immunotherapy

Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Review of deep learning: concepts, CNN architectures, challenges, applications, future directions

Prognostic factors for survival in melanoma patients with brain metastases

Applications of artificial intelligence in battling against covid-19: A literature review

VEGF in Signaling and Disease: Beyond Discovery and Development

MicroRNA

Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Nanotechnology for Multimodal Synergistic Cancer Therapy

Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia

Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade

Using machine learning of clinical data to diagnose COVID-19: a systematic review and meta-analysis

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases

Cigarette Smoke Promotes Drug Resistance and Expansion of Cancer Stem Cell-Like Side Population

EGFR Kinase Promotes Acquisition of Stem Cell-Like Properties: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma Stem Cells

Potential Role of Imatinib Mesylate (Gleevec, STI-571) in the Treatment of Vestibular Schwannoma

Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy

Safety and antitumor activity of hypofractionated stereotactic irradiation (HFSRT) with pembrolizumab (Pembro) and bevacizumab (Bev) in patients (pts) with recurrent high grade gliomas: Preliminary results from phase I study.

Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide.